These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 805187)

  • 1. Bacteriophages and endotoxin in licensed live-virus vaccines.
    Moody EE; Trousdale MD; Jorgensen JH; Shelokov A
    J Infect Dis; 1975 May; 131(5):588-91. PubMed ID: 805187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteriophages in live virus vaccines.
    Petricciani JC; Chu FC; Johnson JB; Meyer HM
    Proc Soc Exp Biol Med; 1973 Dec; 144(3):789-92. PubMed ID: 4797300
    [No Abstract]   [Full Text] [Related]  

  • 3. Application of PCR for detection of mycoplasma DNA and pestivirus RNA in human live viral vaccines.
    Sasaki T; Harasawa R; Shintani M; Fujiwara H; Sasaki Y; Horino A; Kenri T; Asada K; Kato I; Chino F
    Biologicals; 1996 Dec; 24(4):371-5. PubMed ID: 9088554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impotency of live-virus vaccines as a result of improper handling in clinical practice.
    Krugman RD; Meyer BC; Enterline JC; Parkman PD; Witte JJ; Meyer HM
    J Pediatr; 1974 Oct; 85(4):512-4. PubMed ID: 4443859
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence of pestivirus RNA in human virus vaccines.
    Harasawa R; Tomiyama T
    J Clin Microbiol; 1994 Jun; 32(6):1604-5. PubMed ID: 8077414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tests for the presence of bacteriophages in live virus vaccine].
    Albrycht H; Wysokińska T; Sporzyńska Z; Rymkiewicz D; Banach W
    Med Dosw Mikrobiol; 1981; 33(2):97-103. PubMed ID: 6272037
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antigenicity of 4 antiviral vaccines].
    Ruiz-Gómez J
    Gac Med Mex; 1973 Jun; 105(6):599-608. PubMed ID: 4731998
    [No Abstract]   [Full Text] [Related]  

  • 8. A European collaborative study to assess the proficiency of laboratory estimates of potency of live measles, mumps and rubella tri-valent vaccines.
    Forsey T; Heath AB; Minor PD
    Biologicals; 1993 Sep; 21(3):239-49. PubMed ID: 8117437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability characteristics of freeze-dried human live virus vaccines.
    Cowdery S; Frey M; Orlowski S; Gray A
    Dev Biol Stand; 1976 Oct; 36():297-303. PubMed ID: 1030428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of vaccines, interferons and cell substrates for pestivirus contamination.
    Audet SA; Crim RL; Beeler J
    Biologicals; 2000 Mar; 28(1):41-6. PubMed ID: 10799055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newer viral vaccines: measles, mumps and rubella.
    Krugman S
    Schweiz Rundsch Med Prax; 1975 Feb; 64(5):124-8. PubMed ID: 1215313
    [No Abstract]   [Full Text] [Related]  

  • 12. New recommendations for simultaneous administration of live virus vaccines.
    Reeve AM
    J Iowa Med Soc; 1973 Feb; 63(2):50 passim. PubMed ID: 4687453
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of animals in the development and control of viral vaccines.
    Minor PD
    Dev Biol Stand; 1996; 86():113-20. PubMed ID: 8785940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical safety issues of measles, mumps and rubella vaccines.
    Afzal MA; Minor PD; Schild GC
    Bull World Health Organ; 2000; 78(2):199-204. PubMed ID: 10743285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability on storage at various temperatures of live measles, mumps and rubella virus vaccines in new stabilizer.
    McAleer WJ; Markus HZ; McLean AA; Buynak EB; Hilleman MR
    J Biol Stand; 1980; 8(4):281-7. PubMed ID: 7009615
    [No Abstract]   [Full Text] [Related]  

  • 16. Bacteriophage contamination in live poliovirus vaccine.
    Milch H; Fornosi F
    J Biol Stand; 1975; 3(3):307-10. PubMed ID: 1158904
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of adverse storage on live virus vaccines.
    Finter NB; Ferris R; Kelly A; Prydie J
    Dev Biol Stand; 1978; 41():271-6. PubMed ID: 753656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The value of the first and second measles-mumps-rubella immunization according to the STIKO (Permanent Immunization Committee) recommendations. Interview by Marianne E Tippmann].
    Stück B
    Kinderkrankenschwester; 2000 Jan; 19(1):25-7. PubMed ID: 10734856
    [No Abstract]   [Full Text] [Related]  

  • 19. Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Watson JC; Hadler SC; Dykewicz CA; Reef S; Phillips L
    MMWR Recomm Rep; 1998 May; 47(RR-8):1-57. PubMed ID: 9639369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Viral vaccines--current status and developmental trends].
    Starke G
    Z Arztl Fortbild (Jena); 1971 May; 65(9-10):495-503. PubMed ID: 4940028
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.